Category: Biopsy

For decades, standard TRUS biopsies relied on 12+ random needles—missing aggressive cancers up to 46% of the time and increasing risks of infection. Today, real-time MRI-guided biopsies use just 2–4 precisely targeted needles, giving doctors clearer answers with fewer side effects. Discover why MRI-guided precision is changing prostate cancer diagnosis. keep reading

New tools like biomarker tests and 3T mpMRI are transforming how doctors evaluate a high PSA. Learn how these innovations reduce unnecessary prostate biopsies—saving patients from risk, stress, and costs—while delivering greater clarity in prostate cancer diagnosis. keep reading

If you’re a real estate developer planning to build a new house, you start with the groundwork—literally. Before you start excavating, you have analysts determine the basics: the type of soil, the water table, and any flood risk. You want to know the important foundation factors that help predict the future stability of the construction. keep reading

Research shows that only three needles may be required for an accurate in-bore MRI-guided biopsy. This approach reduces patient discomfort, shortens procedure time, and maintains high diagnostic accuracy compared to traditional methods involving more needles. keep reading

Let’s start with the hypothetical case of Robert. He considers himself lucky in life because good things have come his way. He has a happy marriage, nice kids, a decent job, and he’s healthy. He follows the principles of the Mediterranean diet, doesn’t smoke, and has an occasional glass of wine. He does cardio workouts keep reading

Numerous studies have validated the hypothesis that if mpMRI does not detect significant prostate cancer (PCa), no biopsy is needed; but if a biopsy is indicated, MRI-targeted biopsy overcomes the problems of the TRUS random biopsies. It minimizes the number of needles while maximizing diagnostic accuracy. As one paper states... keep reading

When you’re in a hurry to get somewhere, you’re likely to take the path of least resistance, the route you’re most familiar with. It’s easy because you know it well. However, when it comes to knowing whether or not you have prostate cancer (PCa), the most familiar route is not always the best way to keep reading

Ongoing research since we posted the blog below continues to support the need for more diagnostic indicators before performing repeat biopsy after an initial negative biopsy. Repeat biopsies increase the risk of side effects, with a “3.9-fold increase in serious infectious complications and a 16.1-fold increase in noninfectious urological complications…” keep reading

When it comes to prostate cancer, your body comes equipped with a kind of check engine light. It’s your PSA blood test. If it comes back abnormally high or rising, it’s a physical uh-oh. Like a check engine light, it doesn’t tell you exactly what the problem is. A doctor’s next step might well be a conventional 12+ core, with its risks of inaccuracy and side effects. What if there were a simpler way to assemble and evaluate vital information in a single step, such as a blood draw? keep reading

If you want your home to outsmart your neighbor’s, you can count on robotics to make you the leader on the block. Today’s smart home is equipped with robots that are trusted to mop floors, wash windows, tutor your tots, and even become your canine best friend! [Note: links to products are intended only as keep reading